Literature DB >> 16979900

Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?

Elizabeth S Evans1, Zafer Kocak, Su-Min Zhou, Daniel A Kahn, Hong Huang, Donna R Hollis, Kim L Light, Mitchell S Anscher, Lawrence B Marks.   

Abstract

The purpose of the study was to reassess the utility of transforming growth factor-beta-1 (TGF-beta1) together with dosimetric and tumor parameters as a predictor for radiation pneumonitis (RP). Of the 121 patients studied, 32 (26.4%) developed grade > or =1 RP, and 27 (22.3%) developed grade > or =2 RP. For the endpoint of grade > or =1 RP, those with V30>30% and an end-RT/baseline TGF-beta1 ratio> or =1 had a significantly higher incidence of RP than did those with V30>30% and an end-RT/baseline TGF-beta1 ratio<1. For most other patient groups, there were no clear associations between TGF-beta1 values and rates of RP. These findings suggest that TGF-beta1 is generally not predictive for RP except for the group of patients with a high V30.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979900      PMCID: PMC1829192          DOI: 10.1016/j.cyto.2006.07.021

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  39 in total

Review 1.  Role of transforming growth factor beta in human disease.

Authors:  G C Blobe; W P Schiemann; H F Lodish
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints.

Authors:  L B Marks; M Fan; R Clough; M Munley; G Bentel; R E Coleman; R Jaszczak; D Hollis; M Anscher
Journal:  Int J Radiat Biol       Date:  2000-04       Impact factor: 2.694

3.  Incorporation of functional status into dose-volume analysis.

Authors:  L B Marks; G W Sherouse; M T Munley; G C Bentel; D P Spencer
Journal:  Med Phys       Date:  1999-02       Impact factor: 4.071

4.  Cytokine profiling for prediction of symptomatic radiation-induced lung injury.

Authors:  Justin P Hart; Gloria Broadwater; Zahid Rabbani; Benjamin J Moeller; Robert Clough; Dale Huang; Gregory A Sempowski; Mark Dewhirst; Salvatore V Pizzo; Zeljko Vujaskovic; Mitchell S Anscher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-22       Impact factor: 7.038

Review 5.  How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues.

Authors:  M H Barcellos-Hoff
Journal:  Radiat Res       Date:  1998-11       Impact factor: 2.841

6.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

Authors:  M V Graham; J A Purdy; B Emami; W Harms; W Bosch; M A Lockett; C A Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

7.  Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis.

Authors:  M S Anscher; F M Kong; K Andrews; R Clough; L B Marks; G Bentel; R L Jirtle
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-15       Impact factor: 7.038

8.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.

Authors:  S L Kwa; J V Lebesque; J C Theuws; L B Marks; M T Munley; G Bentel; D Oetzel; U Spahn; M V Graham; R E Drzymala; J A Purdy; A S Lichter; M K Martel; R K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-08-01       Impact factor: 7.038

9.  Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients.

Authors:  C Asselin-Paturel; H Echchakir; G Carayol; F Gay; P Opolon; D Grunenwald; S Chouaib; F Mami-Chouaib
Journal:  Int J Cancer       Date:  1998-07-03       Impact factor: 7.396

10.  Regional dose response to pulmonary irradiation using a manual method.

Authors:  B Levinson; L B Marks; M T Munley; J Poulson; D Hollis; R Jaszczak; R E Coleman
Journal:  Radiother Oncol       Date:  1998-07       Impact factor: 6.280

View more
  15 in total

1.  Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer.

Authors:  Xiaoxiang Guan; Erich M Sturgis; Dapeng Lei; Zhensheng Liu; Kristina R Dahlstrom; Qingyi Wei; Guojun Li
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

Review 2.  Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects.

Authors:  Søren M Bentzen; Matthew Parliament; Joseph O Deasy; Adam Dicker; Walter J Curran; Jacqueline P Williams; Barry S Rosenstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 3.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

4.  Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship.

Authors:  Peter G Hawkins; Philip S Boonstra; Stephen T Hobson; Jason W D Hearn; James A Hayman; Randall K Ten Haken; Martha M Matuszak; Paul Stanton; Gregory P Kalemkerian; Nithya Ramnath; Theodore S Lawrence; Matthew J Schipper; Feng-Ming Spring Kong; Shruti Jolly
Journal:  Radiother Oncol       Date:  2017-09-23       Impact factor: 6.280

Review 5.  Nondosimetric risk factors for radiation-induced lung toxicity.

Authors:  Feng-Ming Spring Kong; Shulian Wang
Journal:  Semin Radiat Oncol       Date:  2014-12-15       Impact factor: 5.934

6.  Serum transforming growth factor-beta1 level reflects disease status in patients with esophageal carcinoma after radiotherapy.

Authors:  Su-Ping Sun; Ye-Ning Jin; Hong-Peng Yang; Yi Wei; Zhao Dong
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

7.  Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy.

Authors:  Ken Dornfeld; Shane Hopkins; Joel Simmons; Douglas R Spitz; Yusuf Menda; Michael Graham; Russell Smith; Gerry Funk; Lucy Karnell; Michael Karnell; Maude Dornfeld; Min Yao; John Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

8.  Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.

Authors:  Xianglin Yuan; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Susan L Tucker; Li Mao; Xin Shelley Wang; Mary Martel; Ritsuko Komaki; James D Cox; Luka Milas; Qingyi Wei
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

Review 9.  Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.

Authors:  Yaacov Richard Lawrence; Maria Werner-Wasik; Adam P Dicker
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

Review 10.  Molecular markers of radiation-related normal tissue toxicity.

Authors:  Paul Okunieff; Yuhchyau Chen; David J Maguire; Amy K Huser
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.